Search Results - "Nielsen, Peter B."

Cardiovascular Risk in Young Patients Diagnosed With Obstructive Sleep Apnea by Albertsen, Ida E, Bille, Jesper, Piazza, Gregory, Lip, Gregory Y H, Nielsen, Peter B

“…In older adults, obstructive sleep apnea (OSA) has been associated with several cardiovascular complications. Whether young patients diagnosed with OSA also…”
Get full text

Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study by Larsen, Torben B, Dr, Skjøth, Flemming, PhD, Kjældgaard, Jette N, BSc, Lip, Gregory Y H, Prof, Nielsen, Peter B, PhD, Søgaard, Mette, PhD

“…Summary Background Deep vein thrombosis (DVT) and pulmonary embolism are collectively known as venous thromboembolism (VTE), which is a common vascular disease…”
Get full text

Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy by Lip, Gregory Y H, Skjøth, Flemming, Nielsen, Peter B, Larsen, Torben Bjerregaard

“…Oral anticoagulation (OAC) to prevent stroke has to be balanced against the potential harm of serious bleeding, especially intracranial haemorrhage (ICH). We…”
Get more information

Revascularisation for Symptomatic Peripheral Artery Disease: External Applicability of the VOYAGER PAD Trial by Søgaard, Mette, Nielsen, Peter B., Skjøth, Flemming, Larsen, Torben B., Eldrup, Nikolaj

“…In the VOYAGER PAD trial, rivaroxaban 2.5 mg plus aspirin significantly reduced the primary composite efficacy outcome of acute limb ischaemia, major…”
Get full text

The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study by Overvad, Thure F., Skjøth, Flemming, Piazza, Gregory, Noble, Simon, Ording, Anne G., Larsen, Torben B., Nielsen, Peter B.

“…Background Thrombosis is common among patients with cancer. Primary thromboprophylaxis guided by the Khorana score is endorsed by guidelines but…”
Get full text

Long-term antithrombotic treatment in intracranial hemorrhage survivors with atrial fibrillation by Korompoki, Eleni, Filippidis, Filippos T, Nielsen, Peter B, Del Giudice, Angela, Lip, Gregory Y H, Kuramatsu, Joji B, Huttner, Hagen B, Fang, Jiming, Schulman, Sam, Martí-Fàbregas, Joan, Gathier, Celine S, Viswanathan, Anand, Biffi, Alessandro, Poli, Daniela, Weimar, Christian, Malzahn, Uwe, Heuschmann, Peter, Veltkamp, Roland

“…OBJECTIVE:To perform a systematic review and meta-analysis of studies reporting recurrent intracranial hemorrhage (ICH) and ischemic stroke (IS) in ICH…”
Get full text

Temporal trends in abdominal aortic aneurysmal disease: a nationwide cohort study on cardiovascular morbidity and medical cardioprotective therapy by Nicolajsen, Chalotte W, Søgaard, Mette, Eldrup, Nikolaj, Jensen, Martin, Larsen, Torben B, Goldhaber, Samuel Z, Nielsen, Peter B

“…Abdominal aortic aneurysmal disease is associated with increased risk of cardiovascular morbidity and death, which potentially can be reduced with…”
Get full text

Incidence of venous thromboembolism following head and neck surgery by Albertsen, Ida E., Lyhne, Nina M., Larsen, Torben B., Nielsen, Peter B.

“…Purpose Venous thromboembolism (VTE) is associated with significant morbidity and mortality in patients undergoing surgery, but conflicting data exist on VTE…”
Get full text

Stroke and Myocardial Infarction in Patients with Abdominal Aortic Aneurysm and New-Onset Atrial Fibrillation by Nicolajsen, Chalotte W, Nielsen, Peter B, Jensen, Martin, Eldrup, Nikolaj, Larsen, Torben B, Lip, Gregory Y H, Goldhaber, Samuel Z, Søgaard, Mette

“…We investigated the association between new-onset atrial fibrillation (AF) and risk of stroke and myocardial infarction (MI) in patients with abdominal aortic…”
Get more information

The effect of pH on fatigue during submaximal isometric contractions of the human calf muscle by Siegler, Jason C., Marshall, Paul, Pouslen, Mathias K., Nielsen, Niels-Peter B., Kennedy, David, Green, Simon

“…Purpose This study examined whether changes in pH throughout the physiologic range would have a differential effect on central and peripheral factors…”
Get full text

Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) by Lip, Gregory Y.H., Skjøth, Flemming, Rasmussen, Lars Hvilsted, Nielsen, Peter B., Larsen, Torben Bjerregaard

“…Whether to anticoagulate patients with atrial fibrillation (AF) and 1 stroke risk factor (i.e., CHA2DS2-VASc [congestive heart failure, hypertension, age >75…”
Get full text

Comparative effectiveness and safety of edoxaban versus warfarin in patients with atrial fibrillation: A nationwide cohort study by Nielsen, Peter B, Søgaard, Mette, Jensen, Martin, Ording, Anne G, Lip, Gregory YH

“…Background and purpose The effectiveness and safety of edoxaban 60 mg and 30 mg for stroke prevention compared with warfarin in patients with atrial…”
Get full text

Type 1 versus type 2 diabetes and thromboembolic risk in patients with atrial fibrillation: A Danish nationwide cohort study by Fangel, Mia V., Nielsen, Peter B., Larsen, Torben B., Christensen, Bo, Overvad, Thure F., Lip, Gregory Y.H., Goldhaber, Samuel Z., Jensen, Martin B.

“…Atrial fibrillation is a common cause of stroke, and diabetes increases stroke risk. Stroke risk may vary depending on the type of diabetes. We investigated…”
Get full text

Thromboembolic and bleeding outcomes in patients with atrial fibrillation and valvular heart disease: A descriptive nationwide cohort study by Melgaard, Line, Jensen, Martin, Overvad, Thure F, Larsen, Torben B, Lip, Gregory Y H, Nielsen, Peter B

“…The risks of thromboembolism and bleeding in patients with atrial fibrillation (AF) and valvular heart disease (VHD) are sparsely described. We described the…”
Get more information

Thromboembolic Risk in Patients With Pneumonia and New-Onset Atrial Fibrillation Not Receiving Anticoagulation Therapy by Søgaard, Mette, Skjøth, Flemming, Nielsen, Peter B, Smit, Jesper, Dalager-Pedersen, Michael, Larsen, Torben B, Lip, Gregory Y H

“…New-onset atrial fibrillation (AF) is commonly reported in patients with severe infections. However, the absolute risk of thromboembolic events without…”
Get full text

Antiplatelet Therapy in Patients With Abdominal Aortic Aneurysm Without Symptomatic Atherosclerotic Disease by Nicolajsen, Chalotte W., Søgaard, Mette, Jensen, Martin, Eldrup, Nikolaj, Larsen, Torben B., Goldhaber, Samuel Z., Behrendt, Christian-Alexander, Nielsen, Peter B.

“…Importance Patients with abdominal aortic aneurysm have a high risk of ischemic events associated with concomitant atherosclerotic cardiovascular disease, and…”
Get full text

Sample-to-SNP kit: A reliable, easy and fast tool for the detection of HFE p.H63D and p.C282Y variations associated to hereditary hemochromatosis by Nielsen, Peter B., Petersen, Maja S., Ystaas, Viviana, Andersen, Rolf V., Hansen, Karin M., Blaabjerg, Vibeke, Refstrup, Mette

“…Classical hereditary hemochromatosis involves the HFE-gene and diagnostic analysis of the DNA variants HFE p.C282Y (c.845G>A; rs1800562) and HFE p.H63D…”
Get full text

common Greenlandic Inuit BRCA1 RING domain founder mutation by Hansen, Thomas v. O, Ejlertsen, Bent, Albrechtsen, Anders, Bergsten, Eva, Bjerregaard, Peter, Hansen, Torben, Myrhøj, Torben, Nielsen, Peter B, Timmermans-Wielenga, Vera, Andersen, Mette K, Jønson, Lars, Nielsen, Finn C

“…Germ-line mutations in the tumour suppressor proteins BRCA1 and BRCA2 predispose to breast and ovarian cancer. We examined 32 breast and/or ovarian cancer…”
Get full text

Abstract 10177: Optimal Reperfusion Strategy in Acute High-Risk Pulmonary Embolism Requiring Extracorporeal Membrane Oxygenation Support: A Systematic Review and Meta-Analysis by Chopard, Romain, Nielsen, Peter B, Ius, Fabio, Ecarnot, Fiona, Pilichowski, Hugo, Piazza, Gregory, Meneveau, Nicolas

“…IntroductionThe optimal pulmonary revascularization strategy in acute high-risk pulmonary embolism (PE) requiring the implantation of extra corporeal membrane…”
Get full text

Net Clinical Benefit for Oral Anticoagulation, Aspirin, or No Therapy in Nonvalvular Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2 DS2 -VASc Score (Beyond Sex) by Lip, Gregory Y.H., MD, Skjøth, Flemming, MSc, PhD, Rasmussen, Lars Hvilsted, MD, PhD, Nielsen, Peter B., PhD, Larsen, Torben Bjerregaard, MD, PhD

Get full text